Author: Alexander Lee
Alexander Lee
Alexander is the founder and author of Microcaps.ca, a leading resource for investors interested in the micro-cap stock market. With a passion for uncovering hidden gems in the world of small-cap stocks, Alexander combines in-depth research with years of experience in the financial markets to provide readers with valuable insights and timely analysis. Investors should conduct their own research or consult with a qualified investment advisor before making any investment decisions. The author of this article is not responsible for any gains or losses incurred from investing in companies mentioned.
On August 14, 2024, Atomic Minerals Corp. announced plans for its initial prospecting program at its 100% owned Archie Lake Project in northern Saskatchewan. The company has partnered with Grander Exploration Ltd. to conduct an extensive grab and chip sampling program on the 264-hectare property to explore basement-hosted uranium mineralization in the area. Grander has identified target areas TZ1 and TZ2 after a detailed review of historic geophysical data. A scintillometer survey with 25-meter spacing will be conducted to cover the entire property, with a focus on TZ1 and TZ2. Any anomalous areas will be soil sampled and examined for…
Calgary, Alberta–(Newsfile Corp. – August 12, 2024) – Cardinal Energy Ltd. (TSX: CJ) has officially announced its upcoming dividend payment of $0.06 per common share, scheduled to be disbursed on September 16, 2024 to shareholders who are recorded as owners on August 30, 2024. The Board of Directors of Cardinal has authorized the payment of this dividend in cash, with the dividend being classified as an “eligible dividend” for Canadian income tax purposes. Cardinal Energy Ltd. is a Canadian company engaged in the exploration and production of oil and natural gas resources.
On August 14, 2024, in Edmonton, Alberta, Bri-Chem Corp. (TSX: BRY), a leading oilfield chemical distribution and blending company in North America, announced its financial results for the second quarter of 2024. Key highlights from the second quarter of 2024 include a 24% decrease in consolidated sales compared to the prior year, primarily due to reduced US drilling activities. Gross margin also decreased by $976 thousand, mainly related to a decline in sales in the fluids distribution division. Adjusted EBITDA for the second quarter of 2024 declined by $1.3 million compared to the same period in the prior year, and…
NewRange Copper Nickel has announced a new team with global expertise that will oversee four key studies over the next year to evaluate new mining technology and sustainability developments for the NorthMet project. The team’s focus on tailings storage, water science, efficient production, and carbon reduction will ensure that the project remains at the forefront of responsible clean energy mineral resource development. These studies are crucial as the NorthMet project represents one of the largest undeveloped copper and nickel deposits in the world. By supporting the United States’ clean energy transition and creating a domestic supply chain for clean energy…
On August 19, 2024, Millbank Mining Corp. (TSXV: MILL) announced that it will not be proceeding with the proposed name change as stated in a previous press release dated August 8, 2024. The company has clarified that it currently does not have any involvement in natural hydrogen projects, and any future acquisitions in this area would require approval from the TSX Venture Exchange. Millbank Mining Corp. is a mineral exploration company that is currently focusing on its wholly owned and royalty-free Arthur Lake property in British Columbia. For more information, please contact the company directly. The company would like to…
Satellos Biosciences (TSX:MSCL) has recently obtained approval to initiate a Phase 1 clinical trial in Australia for a new drug called SAT-3247. This medication aims to target regenerating skeletal muscle in patients with Duchenne muscular dystrophy (DMD). The trial will involve an initial assessment of SAT-3247 in 72 healthy volunteers followed by 10 DMD patients. The company disclosed that the trial is anticipated to commence in Q3. DMD is a debilitating form of muscular dystrophy that predominantly affects boys, with muscle weakness typically appearing around the age of 4. Satellos Biosciences is enthusiastic about advancing SAT-3247 into first-in-human studies as…
On August 19, 2024, PharmaDrug Inc. announced that its subsidiary, Sairiyo Therapeutics Inc., has received approval from the Australian Human Research Ethics Committee to commence a Phase 1 clinical study. The study will investigate a patented reformulated enteric coated version of oral cepharanthine (“PD-001”) for potential treatment in Medical Countermeasures and cancer. PD-001 was previously awarded a contract for the Ebola virus research. PharmaDrug’s CEO, Robert Steen, expressed enthusiasm for this milestone, highlighting the product’s potential in treating various diseases. The completion of this study will support the submission of an Investigational New Drug application for PD-001 to the U.S.…
On August 15, 2024, Argo Gold Inc., a Toronto-based company, reported its oil production figures for the month of June 2024. The company produced a total of 3,214 barrels for the month, averaging 107.5 barrels per day. The average oil price for the month was CDN$80.85 per barrel, resulting in June oil revenue of $259,855 and a net operating cash flow of $170,750. The breakdown of Argo Gold’s oil production for June 2024 is as follows: – Lindbergh 1 (37.5% interest): 105 barrels per day, with 39.5 barrels per day being Argo’s interest. The oil revenue generated from Lindbergh 1…
August 15, 2024 9:00 AM EDT | Source: Great Atlantic Resources Corp. Vancouver, British Columbia–(Newsfile Corp. – August 15, 2024) – Great Atlantic Resources Corp. (TSXV: GR) is pleased to announce that its wholly-owned subsidiary, Golden Promise Mines Inc., has initiated the 2024 exploration program at the East Golden Promise Gold Property situated in central Newfoundland, east of the Company’s flagship Golden Promise Gold Property. The exploration work is centered on a new target area where Great Atlantic has identified gold soil anomalies and anomalous levels of gold in rock samples from previous work conducted in 2021-2022. Exploration at…
August 19, 2024 6:52 PM EDT | Source: Peruvian Metals Corp. Edmonton, Alberta–(Newsfile Corp. – August 19, 2024) – Peruvian Metals Corp. (TSXV: PER) (OTCQB: DUVNF) (“Peruvian Metals” or the “Company”), a Canadian exploration and mineral processing company with operations in Peru, is issuing its second bi-weekly default status report in compliance with National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). The Company had applied for a management cease trade order (“MCTO”) with the Alberta Securities Commission (“ASC”) on July 22, 2024, due to the delay in filing its audited annual financial statements for the year ended…